Medinter Ltd

General

Total Cases1
Active Cases--
Patents--
TypeOperating Company
Elite Ratings
--
--
--
--

Ratings

Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
09/01/23
Letter to The Honorable Joshua D. Wolson from Zachary J. Schnapp regarding the Court's Order dated August 24, 2023. - re 461 Redacted Document, 460 Redacted Document, 459 Order,,. (Schnapp, Zachary) (Entered: 09/01/2023)
09/01/23
Letter to The Honorable Joshua D. Wolson from Zachary J. Schnapp regarding the Court's Order dated August 24, 2023. - re 461 Redacted Document, 460 Redacted Document, 459 Order,,. (Schnapp, Zachary) (Entered: 09/01/2023)
09/01/23
Letter to The Honorable Joshua D. Wolson from Zachary J. Schnapp regarding the Court's Order dated August 24, 2023. - re 461 Redacted Document, 460 Redacted Document, 459 Order,,. (Schnapp, Zachary) (Entered: 09/01/2023)
09/01/23
Letter to The Honorable Joshua D. Wolson from Zachary J. Schnapp regarding the Court's Order dated August 24, 2023. - re 461 Redacted Document, 460 Redacted Document, 459 Order,,. (Schnapp, Zachary) (Entered: 09/01/2023)
09/01/23
REDACTED VERSION of 452 Reply Brief, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 09/01/2023)
09/01/23
REDACTED VERSION of 452 Reply Brief, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 09/01/2023)
09/01/23
REDACTED VERSION of 452 Reply Brief, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 09/01/2023)
09/01/23
REDACTED VERSION of 452 Reply Brief, by Galderma Laboratories, L.P., Galderma S.A.. (Flynn, Michael) (Entered: 09/01/2023)
09/01/23
REDACTED VERSION of 446 Opening Brief in Support, by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Ex. A, # 2 Ex. B, # 3 Ex. C)(Flynn, Michael) (Entered: 09/01/2023)
09/01/23
REDACTED VERSION of 446 Opening Brief in Support, by Galderma Laboratories, L.P., Galderma S.A.. (Attachments: # 1 Ex. A, # 2 Ex. B, # 3 Ex. C)(Flynn, Michael) (Entered: 09/01/2023)